Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
China Journal of Chinese Materia Medica ; (24): 3108-3113, 2011.
Artículo en Chino | WPRIM | ID: wpr-251186

RESUMEN

<p><b>OBJECTIVE</b>Fufang Kushen injection was selected as the model drug, to optimize its alcohol-purification process and understand the characteristics of particle sedimentation process, and to investigate the feasibility of using process analytical technology (PAT) on traditional Chinese medicine (TCM) manufacturing.</p><p><b>METHOD</b>Total alkaloids (calculated by matrine, oxymatrine, sophoridine and oxysophoridine) and macrozamin were selected as quality evaluation markers to optimize the process of Fufang Kushen injection purification with alcohol. Process parameters of particulate formed in the alcohol-purification, such as the number, density and sedimentation velocity, were also determined to define the sedimentation time and well understand the process.</p><p><b>RESULT</b>The purification process was optimized as that alcohol is added to the concentrated extract solution (drug material) to certain concentration for 2 times and deposited the alcohol-solution containing drug-material to sediment for some time, i.e. 60% alcohol deposited for 36 hours, filter and then 80% -90% alcohol deposited for 6 hours in turn. The content of total alkaloids was decreased a little during the depositing process. The average settling time of particles with the diameters of 10, 25 microm were 157.7, 25.2 h in the first alcohol-purified process, and 84.2, 13.5 h in the second alcohol-purified process, respectively.</p><p><b>CONCLUSION</b>The optimized alcohol-purification process remains the marker compositions better and compared with the initial process, it's time saving and much economy. The manufacturing quality of TCM-injection can be controlled by process. PAT pattern must be designed under the well understanding of process of TCM production.</p>


Asunto(s)
Alcoholes , Alcaloides , Medicamentos Herbarios Chinos , Química , Inyecciones , Tecnología Farmacéutica
2.
China Journal of Chinese Materia Medica ; (24): 666-671, 2011.
Artículo en Chino | WPRIM | ID: wpr-247413

RESUMEN

<p><b>OBJECTIVE</b>To study the key processes of Fufang Kushen injection for technical upgrading.</p><p><b>METHOD</b>Total alkaloids (sum of matrine, oxymatrine, sophoridine and oxysophoridine) and macrozamin were selected as quality evaluation markers. The key processes of percolation with acetic acid and discoloration with activated carbon were optimized by orthogonal experiment design, and process of purification with alcohol was investigated by single factor method.</p><p><b>RESULT</b>The optimal condition of percolation process is as follows: the medicinal materials are soaked for 9 h with 4 times water containing 0.8% acetic acid, then percolation starts at flow-rate of 5 mL x min(-1) x kg(-1) and adding 2 times 0.8% acetic acid solution is added at the same velocity. Purification process is that the concentrated solution is precipitated by 60%, 80% and 90% alcohol in turn. Discoloration process is that 6 activated carbon is added into the solution which is heated at 60 degrees C for 20 minutes.</p><p><b>CONCLUSION</b>The optimal extraction process is not only simple, saving the industrial cycle, reducing the potential risk, but also decreasing the acetic acid amount to guarantee the acid-insoluble ash as well as the functional ingredients.</p>


Asunto(s)
Alcaloides , Medicamentos Herbarios Chinos , Química , Inyecciones , Extractos Vegetales , Tecnología Farmacéutica , Temperatura
3.
Acta Pharmaceutica Sinica ; (12): 263-7, 2010.
Artículo en Chino | WPRIM | ID: wpr-382224

RESUMEN

A series of novel quinolinone acid-containing compounds were designed and synthesized. Their structures were confirmed with 1H NMR and MS. The target compounds were tested for anti-HIV-1 integrase activities in vitro with enzyme linked immunosorbent assay (ELISA). The result showed that D-2, D-4 and D-7 have anti-integrase activity with IC50 < 100 micromol L(-1).

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA